Home › Therapeutic areas › Oncology › Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia (2 companies)

Companies with an active program in Chronic Lymphocytic Leukemia.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
AUTL Autolus Therapeutics HematologyImmunology+3 Rare 1 Approved $290M 12
NRIX Nurix Therapeutics ImmunologyNeurology+1 1 Phase 3 $1.56B 13